Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    Dengue Characterization Contract Award to SUNY Research Foundation

    By Global Biodefense StaffSeptember 15, 2012
    Share
    Facebook LinkedIn Reddit Email

    The United States Army Medical Research Acquisition Activity (USAMRAA), Fort Detrick, MD this week announced an intent to issue a sole source award to the Research Foundation of the State University of New York (SUNY RF), on behalf of Upstate Medical Center, Syracuse, NY.  

    The required services are to utilize proteomics to characterize host immune responses by identifying distinct protein signatures in blood samples collected from individuals following acute dengue virus (DENV) infection or vaccination with a tetravalent live attenuated DENV vaccine.

    Dengue infection is a leading cause of illness and death in the tropics and subtropics. As many as 100 million people are infected yearly. Dengue is caused by any one of four related viruses transmitted by mosquitoes. There are not yet any vaccines to prevent infection with DENV and the most effective protective measures are those that avoid mosquito bites. (CDC Dengue Map)

    Dengue has emerged as a worldwide problem only since the 1950s. Although dengue rarely occurs in the continental United States, it is endemic in Puerto Rico, and in many popular tourist destinations in Latin America and Southeast Asia.

    Further details are available under Solicitation Number: W81XWH12T0489

    Awards Dengue Mosquito-Borne
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleGeneral Dynamics Awarded $42M Contract in Support of Biodefense Research
    Next Article Biodefense Headlines – September 16, 2012

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    Oct 17
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.